BMPS and liver: More questions than answers

Current Pharmaceutical Design

Volumn 18, Issue 27, 2012, Pages 4114-4125

  Herrera, Blanca ^a   Sánchez, Aránzazu ^a   Fabregat, Isabel ^b  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

BMP; Development; Fibrosis; Hepatocellular carcinoma; Iron homeostasis; Liver; Signaling

Indexed keywords

ANTIINFLAMMATORY AGENT; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN 6; BONE MORPHOGENETIC PROTEIN 9; DORSOMORPHIN; LDN 193189; OSTEOGENIC PROTEIN 1; PF 3446962; UNCLASSIFIED DRUG;

APOPTOSIS; CARCINOGENESIS; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; DIFFERENTIATION; GLUCOSE HOMEOSTASIS; HOMEOSTASIS; LIVER; LIVER CARCINOGENESIS; LIVER DEVELOPMENT; LIVER DYSFUNCTION; LIVER FIBROSIS; LIVER FUNCTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SECRETION; REVIEW;

ADULT; ANIMALS; BONE MORPHOGENETIC PROTEINS; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER DISEASES; LIVER NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 84866338318     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161212802430503     Document Type: Review

References (168)

1. Little SC, Mullins MC. Bone morphogenetic protein heterodimers assemble heteromeric type I receptor complexes to pattern the dorsoventral axis Nat Cell Biol 2009; 11: 637-643.
2. Suzuki A, Kaneko E, Maeda J, Ueno N. Mesoderm induction by BMP-4 and -7 heterodimers Biochem Biophys Res Commun 1997; 232: 153-156.
3. Valera E, Isaacs MJ, Kawakami Y, Izpisua Belmonte JC, Choe S. BMP-2/6 heterodimer is more effective than BMP-2 or BMP-6 homodimers as inductor of differentiation of human embryonic stem cells PLoS One 2010; 5: e11167.
4. Sieber C, Kopf J, Hiepen C, Knaus P. Recent advances in BMP receptor signaling Cytokine Growth Factor Rev 2009; 20: 343-355.
5. Miyazono K, Kamiya Y, Morikawa M. Bone morphogenetic protein receptors and signal transduction J Biochem 2010; 147: 35-51.
6. Miyazono K, Maeda S, Imamura T. BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk Cytokine Growth Factor Rev 2005; 16: 251-263.
7. Shi Y, Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus Cell 2003; 113: 685-700.
8. Feng XH, Derynck R. Specificity and versatility in tgf-beta signaling through Smads Annu Rev Cell Dev Biol 2005; 21: 659-693.
9. Greenwald J, Groppe J, Gray P, et al. The BMP7/ActRII extracellular domain complex provides new insights into the cooperative nature of receptor assembly Mol Cell 2003; 11: 605-617.
10. Hartung A, Bitton-Worms K, Rechtman MM, et al. Different routes of bone morphogenic protein (BMP) receptor endocytosis influence BMP signaling Mol Cell Biol 2006; 26: 7791-7805.
11. Lebrin F, Goumans MJ, Jonker L, et al. Endoglin promotes endothelial cell proliferation and TGF-beta/ALK1 signal transduction Embo J 2004; 23: 4018-4028.
12. Pece-Barbara N, Vera S, Kathirkamathamby K, et al. Endoglin null endothelial cells proliferate faster and are more responsive to transforming growth factor beta1 with higher affinity receptors and an activated Alk1 pathway J Biol Chem 2005; 280: 27800-27808.
13. Ray BN, Lee NY, How T, Blobe GC. ALK5 phosphorylation of the endoglin cytoplasmic domain regulates Smad1/5/8 signaling and endothelial cell migration Carcinogenesis 2010; 31: 435-441.
14. David L, Mallet C, Mazerbourg S, Feige JJ, Bailly S. Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells Blood 2007; 109: 1953-1961.
15. Scharpfenecker M, van Dinther M, Liu Z, et al. BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis J Cell Sci 2007; 120: 964-972.
16. Kirkbride KC, Townsend TA, Bruinsma MW, Barnett JV, Blobe GC. Bone morphogenetic proteins signal through the transforming growth factor-beta type III receptor J Biol Chem 2008; 283: 7628-7637.
17. Lee NY, Kirkbride KC, Sheu RD, Blobe GC. The transforming growth factor-beta type III receptor mediates distinct subcellular trafficking and downstream signaling of activin-like kinase (ALK)3 and ALK6 receptors Mol Biol Cell 2009; 20: 4362-4370.
18. Lopez-Casillas F, Payne HM, Andres JL, Massague J. Betaglycan can act as a dual modulator of TGF-beta access to signaling receptors: mapping of ligand binding and GAG attachment sites J Cell Biol 1994; 124: 557-568.
19. Lee JD, Hempel N, Lee NY, Blobe GC. The type III TGF-beta receptor suppresses breast cancer progression through GIPCmediated inhibition of TGF-beta signaling Carcinogenesis 2010; 31: 175-183.
20. You HJ, How T, Blobe GC. The type III transforming growth factor-beta receptor negatively regulates nuclear factor kappa B signaling through its interaction with beta-arrestin2 Carcinogenesis 2009; 30: 1281-1287.
21. Corradini E, Babitt JL, Lin HY. The RGM/DRAGON family of BMP co-receptors Cytokine Growth Factor Rev 2009; 20: 389-398.
22. De Robertis EM. Spemann's organizer and the self-regulation of embryonic fields Mech Dev 2009; 126: 925-941.
23. Walsh DW, Godson C, Brazil DP, Martin F. Extracellular BMPantagonist regulation in development and disease: tied up in knots Trends Cell Biol 2010; 20: 244-256.
24. Zakin L, De Robertis EM. Extracellular regulation of BMP signaling Curr Biol 2010; 20: R89-R92.
25. Ishida W, Hamamoto T, Kusanagi K, et al. Smad6 is a Smad1/5-induced smad inhibitor. Characterization of bone morphogenetic protein-responsive element in the mouse Smad6 promoter J Biol Chem 2000; 275: 6075-6079.
26. Karaulanov E, Knochel W, Niehrs C. Transcriptional regulation of BMP4 synexpression in transgenic Xenopus Embo J 2004; 23: 844-856.
27. Truksa J, Lee P, Beutler E. Two BMP responsive elements, STAT, and bZIP/HNF4/COUP motifs of the hepcidin promoter are critical for BMP, SMAD1, and HJV responsiveness Blood 2009; 113: 688-695.
28. Korchynskyi O, ten Dijke P. Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter J Biol Chem 2002; 277: 4883-4891.
29. Gamell C SA, Bernard O, Rosa JL, Ventura F. The p38/MK2/Hsp25 pathway is required for BMP-2-induced cell migration. PLoS One 2011; 6(1): e16477 2011; 28: E16477.
30. Ortuno MJ, Ruiz-Gaspa S, Rodriguez-Carballo E, et al. p38 regulates expression of osteoblast-specific genes by phosphorylation of Osterix J Biol Chem 2010;
31. Ulsamer A, Ortuno MJ, Ruiz S, et al. BMP-2 induces Osterix expression through up-regulation of Dlx5 and its phosphorylation by p38 J Biol Chem 2008; 283: 3816-3826.
32. Boergermann JH, Kopf J, Yu PB, Knaus P. Dorsomorphin and LDN-193189 inhibit BMP-mediated Smad, p38 and Akt signaling in C2C12 cells Int J Biochem Cell Biol 2010.
33. Yang X, Lee PJ, Long L, Trembath RC, Morrell NW. BMP4 induces HO-1 via a Smad-independent, p38MAPK-dependent pathway in pulmonary artery myocytes Am J Respir Cell Mol Biol 2007; 37: 598-605.
34. Chen X, Liao J, Lu Y, Duan X, Sun W. Activation of the PI3K/Akt Pathway Mediates Bone Morphogenetic Protein 2-Induced Invasion of Pancreatic Cancer Cells Panc-1. Pathol Oncol Res 2011; 17: 257-261.
35. Barneda-Zahonero B, Minano-Molina A, Badiola N, et al. Bone morphogenetic protein-6 promotes cerebellar granule neurons survival by activation of the MEK/ERK/CREB pathway Mol Biol Cell 2009; 20: 5051-5063.
36. Gamell C, Osses N, Bartrons R, et al. BMP2 induction of actin cytoskeleton reorganization and cell migration requires PI3-kinase and Cdc42 activity J Cell Sci 2008; 121: 3960-3970.
37. Ghosh-Choudhury N, Abboud SL, Nishimura R, et al. Requirement of BMP-2-induced phosphatidylinositol 3-kinase and Akt serine/threonine kinase in osteoblast differentiation and Smaddependent BMP-2 gene transcription J Biol Chem 2002; 277: 33361-33368.
38. Grijelmo C, Rodrigue C, Svrcek M, et al. Proinvasive activity of BMP-7 through SMAD4/src-independent and ERK/Rac/JNKdependent signaling pathways in colon cancer cells Cell Signal 2007; 19: 1722-1732.
39. Pachori AS, Custer L, Hansen D, et al. Bone morphogenetic protein 4 mediates myocardial ischemic injury through JNK-dependent signaling pathway J Mol Cell Cardiol 2010; 48: 1255-1265.
40. Dore JJ, DeWitt JC, Setty N, et al. Multiple signaling pathways converge to regulate bone-morphogenetic-protein-dependent glial gene expression Dev Neurosci 2009; 31: 473-486.
41. Susperregui A, Gamell C, Rodríguez-Carballo E, et al. Noncanonical BMP Signaling Regulates Cyclooxygenase-2 Transcription. Mol Endocrinol 2011; Mar.
42. Haynes T, Gutierrez C, Aycinena JC, Tsonis PA, Del Rio-Tsonis K. BMP signaling mediates stem/progenitor cell-induced retina regeneration Proc Natl Acad Sci USA 2007; 104: 20380-20385.
43. Foletta VC, Lim MA, Soosairajah J, et al. Direct signaling by the BMP type II receptor via the cytoskeletal regulator LIMK1 J Cell Biol 2003; 162: 1089-1098.
44. Theriault BL, Shepherd TG, Mujoomdar ML, Nachtigal MW. BMP4 induces EMT and Rho GTPase activation in human ovarian cancer cells Carcinogenesis 2007; 28: 1153-1162.
45. Ma C, Liu Y, He L. MicroRNAs - powerful repression comes from small RNAs Sci China C Life Sci 2009; 52: 323-330.
46. Wahid F, Shehzad A, Khan T, Kim YY. MicroRNAs: Synthesis, mechanism, function, and recent clinical trials Biochim Biophys Acta 2010; 1803: 1231-1243.
47. Samavarchi-Tehrani P, Golipour A, David L, et al. Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming Cell Stem Cell 2010; 7: 64-77.
48. Mizuno Y, Tokuzawa Y, Ninomiya Y, et al. miR-210 promotes osteoblastic differentiation through inhibition of AcvR1b FEBS Lett 2009; 583: 2263-2268.
49. Lin EA, Kong L, Bai XH, Luan Y, Liu CJ. MiR-199a, a bone morphogenic protein 2-responsive MicroRNA, regulates chondrogenesis via direct targeting to Smad1 J Biol Chem 2009; 284: 11326-11335.
50. Li Z, Hassan MQ, Volinia S, et al. A microRNA signature for a BMP2-induced osteoblast lineage commitment program Proc Natl Acad Sci USA 2008; 105: 13906-13911.
51. Wang J, Greene S, Bonilla-Claudio M, et al. Bmp signaling regulates myocardial differentiation from cardiac progenitors through a MicroRNA-mediated mechanism. Dev Cell 2010; 19(6): 903-912 2010; 19: 901-12.
52. Davis BN, Hilyard AC, Lagna G, Hata A. SMAD proteins control DROSHA-mediated microRNA maturation Nature 2008; 454: 56-61.
53. Davis BN, Hilyard AC, Nguyen PH, Lagna G, Hata A. Smad proteins bind a conserved RNA sequence to promote microRNA maturation by Drosha Mol Cell 2010; 39: 373-384.
54. Reinke CA, Carthew RW. BMP signaling goes posttranscriptional in a microRNA sort of way Dev Cell 2008; 15: 174-175.
55. Xia Y, Babitt JL, Sidis Y, Chung RT, Lin HY. Hemojuvelin regulates hepcidin expression via a selective subset of BMP ligands and receptors independently of neogenin Blood 2008; 111: 5195-5204.
56. Sugimoto H, Yang C, LeBleu VS, et al. BMP-7 functions as a novel hormone to facilitate liver regeneration Faseb J 2007; 21: 256-264.
57. Arndt S, Maegdefrau U, Dorn C, et al. Iron-induced expression of bone morphogenic protein 6 in intestinal cells is the main regulator of hepatic hepcidin expression in vivo Gastroenterology 2010; 138: 372-382.
58. Danesh SM, Villasenor A, Chong D, Soukup C, Cleaver O. BMP and BMP receptor expression during murine organogenesis Gene Expr Patterns 2009; 9: 255-265.
59. Zilberberg L, ten Dijke P, Sakai LY, Rifkin DB. A rapid and sensitive bioassay to measure bone morphogenetic protein activity BMC Cell Biol 2007; 8: 41.
60. Bidart M, Ricard N, Levet S, et al. BMP9 is produced by hepatocytes and circulates mainly in an active mature form complexed to its prodomain Cell Mol Life Sci 2011.
61. Shen H, Huang G, Hadi M, et al. Transforming growth factor-beta1 downregulation of Smad1 gene expression in rat hepatic stellate cells Am J Physiol Gastrointest Liver Physiol 2003; 285: G539-G546.
62. Miller AF, Harvey SA, Thies RS, Olson MS. Bone morphogenetic protein-9. An autocrine/paracrine cytokine in the liver J Biol Chem 2000; 275: 17937-17945.
63. Zaret KS Liver specification and early morphogenesis Mech Dev 2000; 92: 83-88.
64. Zaret KS, Grompe M Generation and regeneration of cells of the liver and pancreas Science 2008; 322: 1490-1494.
65. Jung J, Zheng M, Goldfarb M, Zaret KS. Initiation of mammalian liver development from endoderm by fibroblast growth factors Science 1999; 284: 1998-2003.
66. Rossi JM, Dunn NR, Hogan BL, Zaret KS. Distinct mesodermal signals, including BMPs from the septum transversum mesenchyme, are required in combination for hepatogenesis from the endoderm Genes Dev 2001; 15: 1998-2009.
67. Dudley AT, Godin RE, Robertson EJ. Interaction between FGF and BMP signaling pathways regulates development of metanephric mesenchyme Genes Dev 1999; 13: 1601-1613.
68. Lyons KM, Pelton RW, Hogan BL. Patterns of expression of murine Vgr-1 and BMP-2a RNA suggest that transforming growth factor-beta-like genes coordinately regulate aspects of embryonic development Genes Dev 1989; 3: 1657-1668.
69. Somi S, Buffing AA, Moorman AF, Van Den Hoff MJ Dynamic patterns of expression of BMP isoforms 2, 4, 5, 6, and 7 during chicken heart development Anat Rec A Discov Mol Cell Evol Biol 2004; 279: 636-651.
70. Winnier G, Blessing M, Labosky PA, Hogan BL. Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse Genes Dev 1995; 9: 2105-2116.
71. Mishina Y, Suzuki A, Ueno N, Behringer RR. Bmpr encodes a type I bone morphogenetic protein receptor that is essential for gastrulation during mouse embryogenesis Genes Dev 1995; 9: 3027-3037.
72. Roelen BA, Goumans MJ, van Rooijen MA, Mummery CL. Differential expression of BMP receptors in early mouse development Int J Dev Biol 1997; 41: 541-549.
73. Eferl R, Sibilia M, Hilberg F, et al. Functions of c-Jun in liver and heart development J Cell Biol 1999; 145: 1049-1061.
74. Sosa-Pineda B. The gene Pax4 is an essential regulator of pancreatic beta-cell development Mol Cells 2004; 18: 289-294.
75. Margagliotti S, Clotman F, Pierreux CE, et al. The Onecut transcription factors HNF-6/OC-1 and OC-2 regulate early liver expansion by controlling hepatoblast migration Dev Biol 2007; 311: 579-589.
76. Zhang W, Yatskievych TA, Cao X, Antin PB. Regulation of Hex gene expression by a Smads-dependent signaling pathway J Biol Chem 2002; 277: 45435-41.
77. Shin D, Shin CH, Tucker J, et al. Bmp and Fgf signaling are essential for liver specification in zebrafish Development 2007; 134: 2041-2050.
78. Cao Y, Knochel S, Oswald F, et al. XBP1 forms a regulatory loop with BMP-4 and suppresses mesodermal and neural differentiation in Xenopus embryos Mech Dev 2006; 123: 84-96.
79. Ader T, Norel R, Levoci L, Rogler LE. Transcriptional profiling implicates TGFbeta/BMP and Notch signaling pathways in ductular differentiation of fetal murine hepatoblasts Mech Dev 2006; 123: 177-194.
80. Rogler CE, Levoci L, Ader T, et al. MicroRNA-23b cluster microRNAs regulate transforming growth factor-beta/bone morphogenetic protein signaling and liver stem cell differentiation by targeting Smads Hepatology 2009; 50: 575-584.
81. Mfopou JK, Chen B, Mateizel I, Sermon K, Bouwens L. Noggin, retinoids, and fibroblast growth factor regulate hepatic or pancreatic fate of human embryonic stem cells Gastroenterology 2010.
82. Shiraki N, Umeda K, Sakashita N, et al. Differentiation of mouse and human embryonic stem cells into hepatic lineages Genes Cells 2008; 13: 731-746.
83. Gouon-Evans V, Boussemart L, Gadue P, et al. BMP-4 is required for hepatic specification of mouse embryonic stem cell-derived definitive endoderm Nat Biotechnol 2006; 24: 1402-1411.
84. Cai J, Zhao Y, Liu Y, et al. Directed differentiation of human embryonic stem cells into functional hepatic cells Hepatology 2007; 45: 1229-1239.
85. Phillips BW, Hentze H, Rust WL, et al. Directed differentiation of human embryonic stem cells into the pancreatic endocrine lineage Stem Cells Dev 2007; 16: 561-578.
86. Shiraki N, Higuchi Y, Harada S, et al. Differentiation and characterization of embryonic stem cells into three germ layers Biochem Biophys Res Commun 2009; 381: 694-699.
87. Erker L, Grompe M. Signaling networks in hepatic oval cell activation Stem Cell Res 2007; 1: 90-102.
88. Gennero L, Roos MA, Sperber K, et al. Pluripotent plasticity of stem cells and liver repopulation Cell Biochem Funct 2010; 28: 178-189.
89. Roetto A, Papanikolaou G, Politou M, et al. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis Nat Genet 2003; 33: 21-22.
90. Nemeth E, Tuttle MS, Powelson J, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization Science 2004; 306: 2090-2093.
91. Nicolas G, Bennoun M, Devaux I, et al. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice Proc Natl Acad Sci USA 2001; 98: 8780-8785.
92. Pigeon C, Ilyin G, Courselaud B, et al. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload J Biol Chem 2001; 276: 7811-7819.
93. Papanikolaou G, Samuels ME, Ludwig EH, et al. Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis Nat Genet 2004; 36: 77-82.
94. Babitt JL, Huang FW, Wrighting DM, et al. Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression Nat Genet 2006; 38: 531-539.
95. Malyszko J. Hemojuvelin: the hepcidin story continues Kidney Blood Press Res 2009; 32: 71-76.
96. Zhang AS, Enns CA. Iron homeostasis: recently identified proteins provide insight into novel control mechanisms J Biol Chem 2009; 284: 711-715.
97. Babitt JL, Huang FW, Xia Y, et al. Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance J Clin Invest 2007; 117: 1933-1939.
98. Casanovas G, Mleczko-Sanecka K, Altamura S, Hentze MW, Muckenthaler MU. Bone morphogenetic protein (BMP)-responsive elements located in the proximal and distal hepcidin promoter are critical for its response to HJV/BMP/SMAD J Mol Med 2009; 87: 471-480.
99. Truksa J, Peng H, Lee P, Beutler E. Bone morphogenetic proteins 2, 4, and 9 stimulate murine hepcidin 1 expression independently of Hfe, transferrin receptor 2 (Tfr2), and IL-6 Proc Natl Acad Sci USA 2006; 103: 10289-10293.
100. Andriopoulos B, Jr., Corradini E, Xia Y, et al. BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism Nat Genet 2009; 41: 482-487.
101. Yu PB, Hong CC, Sachidanandan C, et al. Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism Nat Chem Biol 2008; 4: 33-41.
102. Kautz L, Meynard D, Monnier A, et al. Iron regulates phosphorylation of Smad1/5/8 and gene expression of Bmp6, Smad7, Id1, and Atoh8 in the mouse liver Blood 2008; 112: 1503-1509.
103. Meynard D, Kautz L, Darnaud V, et al. Lack of the bone morphogenetic protein BMP6 induces massive iron overload Nat Genet 2009; 41: 478-481.
104. Steinbicker A, Sachidanandan C, Vonner A, et al. Inhibition of bone morphogenetic protein signaling attenuates anemia associated with inflammation. Blood 2011; 117: 4915-4923.
105. Chaston T, Matak P, Pourvali K, et al. Hypoxia inhibits hepcidin expression in HuH7 hepatoma cells via decreased SMAD4 signaling. Am J Physiol Cell Physiol 2011; 300: C888-C895.
106. Maes K, Nemeth E, Roodman G, et al. In anemia of multiple myeloma, hepcidin is induced by increased bone morphogenetic protein 2. Blood 2010; 116: 3635-3644.
107. Finberg KE, Whittlesey RL, Fleming MD, Andrews NC. Downregulation of Bmp/Smad signaling by Tmprss6 is required for maintenance of systemic iron homeostasis Blood 2010; 115: 3817-3826.
108. Bolondi G, Garuti C, Corradini E, et al. Altered hepatic BMP signaling pathway in human HFE hemochromatosis. Blood Cells Mol Dis 2011; 45: 308-312.
109. Ryan J, Ryan E, Fabre A, Lawless M, Crowe J. Defective bone morphogenic protein signaling underlies hepcidin deficiency in HFE hereditary hemochromatosis. Hepatology 2010; 52: 1266-1273.
110. Chen C, Grzegorzewski KJ, Barash S, et al. An integrated functional genomics screening program reveals a role for BMP-9 in glucose homeostasis Nat Biotechnol 2003; 21: 294-301.
111. Caperuto LC, Anhe GF, Cambiaghi TD, et al. Modulation of bone morphogenetic protein-9 expression and processing by insulin, glucose, and glucocorticoids: possible candidate for hepatic insulinsensitizing substance Endocrinology 2008; 149: 6326-6335.
112. Matsuzaki K. Modulation of TGF-beta signaling during progression of chronic liver diseases Front Biosci 2009; 14: 2923-2934.
113. Inagaki Y, Okazaki I. Emerging insights into Transforming growth factor beta Smad signal in hepatic fibrogenesis Gut 2007; 56: 284-292.
114. Nguyen TQ, Goldschmeding R. Bone morphogenetic protein-7 and connective tissue growth factor: novel targets for treatment of renal fibrosis? Pharm Res 2008; 25: 2416-2426.
115. Weiskirchen R, Meurer SK, Gressner OA, et al. BMP-7 as antagonist of organ fibrosis Front Biosci 2009; 14: 4992-5012.
116. Wang S, Hirschberg R. Bone morphogenetic protein-7 signals opposing transforming growth factor beta in mesangial cells J Biol Chem 2004; 279: 23200-23206.
117. Zeisberg M, Hanai J, Sugimoto H, et al. BMP-7 counteracts TGFbeta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury Nat Med 2003; 9: 964-968.
118. Tacke F, Gabele E, Bataille F, et al. Bone morphogenetic protein 7 is elevated in patients with chronic liver disease and exerts fibrogenic effects on human hepatic stellate cells Dig Dis Sci 2007; 52: 3404-3415.
119. Chayanupatkul M, Honsawek S, Vejchapipat P, Chongsrisawat V, Poovorawan Y. Elevated serum bone morphogenetic protein 7 levels and clinical outcome in children with biliary atresia Eur J Pediatr Surg 2009; 19: 246-250.
120. Kordes C, Sawitza I, Haussinger D. Hepatic and pancreatic stellate cells in focus Biol Chem 2009; 390: 1003-1012.
121. Roskams T. Relationships among stellate cell activation, progenitor cells, and hepatic regeneration Clin Liver Dis 2008; 12: 853-6011.
122. Wiercinska E, Wickert L, Denecke B, et al. Id1 is a critical mediator in TGF-beta-induced transdifferentiation of rat hepatic stellate cells Hepatology 2006; 43: 1032-1041.
123. Meurer S, Tihaa L, Borkham-Kamphorst E, Weiskirchen R. Expression and functional analysis of endoglin in isolated liver cells and its involvement in fibrogenic Smad signalling. Cell Signal 2011; 23: 683-699.
124. Shen H, Fan J, Burczynski F, et al. Increased Smad1 expression and transcriptional activity enhances trans-differentiation of hepatic stellate cells J Cell Physiol 2007; 212: 764-770.
125. Zeisberg M, Yang C, Martino M, et al. Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition J Biol Chem 2007; 282: 23337-23347.
126. Kinoshita K, Iimuro Y, Otogawa K, et al. Adenovirus-mediated expression of BMP-7 suppresses the development of liver fibrosis in rats Gut 2007; 56: 706-714.
127. Gressner OA, Rizk MS, Kovalenko E, Weiskirchen R, Gressner AM. Changing the pathogenetic roadmap of liver fibrosis? Where did it start; where will it go? J Gastroenterol Hepatol 2008; 23: 1024-1035.
128. Dendooven A, van Oostrom O, van der Giezen D, et al. Loss of endogenous bone morphogenetic protein-6 aggravates renal fibrosis. Am J Pathol 2011; 178: 1069-1079.
129. Jenkins R, Fraser D. BMP-6 emerges as a potential major regulator of fibrosis in the kidney. Am J Pathol 2011; 78: 964-965.
130. Massague J. A very private TGF-beta receptor embrace Mol Cell 2008; 29: 149-150.
131. Singh A, Morris RJ. The Yin and Yang of bone morphogenetic proteins in cancer Cytokine Growth Factor Rev 2010; 21: 299-313.
132. Thawani JP, Wang AC, Than KD, et al. Bone morphogenetic proteins and cancer: review of the literature Neurosurgery 2010; 66: 233-246; discussion 246.
133. Herrera B, van Dinther M, Ten Dijke P, Inman GJ. Autocrine bone morphogenetic protein-9 signals through activin receptor-like kinase-2/Smad1/Smad4 to promote ovarian cancer cell proliferation Cancer Res 2009; 69: 9254-9262.
134. Rothhammer T, Wild PJ, Meyer S, et al. Bone morphogenetic protein 7 (BMP7) expression is a potential novel prognostic marker for recurrence in patients with primary melanoma Cancer Biomark 2007; 3: 111-117.
135. Rothhammer T, Poser I, Soncin F, et al. Bone morphogenic proteins are overexpressed in malignant melanoma and promote cell invasion and migration Cancer Res 2005; 65: 448-456.
136. Langenfeld EM, Bojnowski J, Perone J, Langenfeld J. Expression of bone morphogenetic proteins in human lung carcinomas Ann Thorac Surg 2005; 80: 1028-1032.
137. Aoki M, Ishigami S, Uenosono Y, et al. Expression of BMP-7 in human gastric cancer and its clinical significance. Br J Cancer 2011; 104: 714-718.
138. Jones S, Zhang X, Parsons DW, et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses Science 2008; 321: 1801-1806.
139. Howe JR, Sayed MG, Ahmed AF, et al. The prevalence of MADH4 and BMPR1A mutations in juvenile polyposis and absence of BMPR2, BMPR1B, and ACVR1 mutations J Med Genet 2004; 41: 484-4891.
140. Wen XZ, Akiyama Y, Baylin SB, Yuasa Y. Frequent epigenetic silencing of the bone morphogenetic protein 2 gene through methylation in gastric carcinomas Oncogene 2006; 25: 2666-2673.
141. Kang MH, Kim JS, Seo JE, Oh SC, Yoo YA. BMP2 accelerates the motility and invasiveness of gastric cancer cells via activation of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway Exp Cell Res 2010; 316: 24-37.
142. Kang MH, Kang HN, Kim JL, et al. Inhibition of PI3 kinase/Akt pathway is required for BMP2-induced EMT and invasion Oncol Rep 2009; 22: 525-534.
143. Buijs JT, Henriquez NV, van Overveld PG, et al. Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer Cancer Res 2007; 67: 8742-8751.
144. Deng H, Makizumi R, Ravikumar TS, et al. Bone morphogenetic protein-4 is overexpressed in colonic adenocarcinomas and promotes migration and invasion of HCT116 cells Exp Cell Res 2007; 313: 1033-1044.
145. Motoyama K, Tanaka F, Kosaka Y, et al. Clinical significance of BMP7 in human colorectal cancer Ann Surg Oncol 2008; 15: 1530-1537.
146. Pardali E, Goumans MJ, ten Dijke P. Signaling by members of the TGF-beta family in vascular morphogenesis and disease Trends Cell Biol 2010; 20: 556-567.
147. McAllister KA, Grogg KM, Johnson DW, et al. Endoglin, a TGFbeta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1 Nat Genet 1994; 8: 345-351.
148. Okano J, Shiota G, Matsumoto K, et al. Hepatocyte growth factor exerts a proliferative effect on oval cells through the PI3K/AKT signaling pathway Biochem Biophys Res Commun 2003; 309: 298-304.
149. Johnson DW, Berg JN, Baldwin MA, et al. Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2 Nat Genet 1996; 13: 189-195.
150. Gallione CJ, Richards JA, Letteboer TG, et al. SMAD4 mutations found in unselected HHT patients J Med Genet 2006; 43: 793-797.
151. Venkatesha S, Toporsian M, Lam C, et al. Soluble endoglin contributes to the pathogenesis of preeclampsia Nat Med 2006; 12: 642-649.
152. Rodrigues CM, Ma X, Linehan-Stieers C, et al. Ursodeoxycholic acid prevents cytochrome c release in apoptosis by inhibiting mitochondrial membrane depolarization and channel formation Cell Death Differ 1999; 6: 842-854.
153. Urness LD, Sorensen LK, Li DY. Arteriovenous malformations in mice lacking activin receptor-like kinase-1 Nat Genet 2000; 26: 328-331.
154. David L, Feige JJ, Bailly S. Emerging role of bone morphogenetic proteins in angiogenesis Cytokine Growth Factor Rev 2009; 20: 203-212.
155. Cunha SI, Pardali E, Thorikay M, et al. Genetic and pharmacological targeting of activin receptor-like kinase 1 impairs tumor growth and angiogenesis J Exp Med 2010; 207: 85-100, S1-S5.
156. Mitchell D PE, Mulivor AW, Grinberg AV, et al. ALK1-Fc inhibits multiple mediators of angiogenesis and suppresses tumor growth. Mol Cancer Ther 2010; 9 379-388.
157. Cunha S, Pietras K. ALK1 as an emerging target for antiangiogenic therapy of cancer. Blood 2011.
158. Sun HC, Tang ZY Angiogenesis in hepatocellular carcinoma: the retrospectives and perspectives J Cancer Res Clin Oncol 2004; 130: 307-319.
159. Rider C, Mulloy B. Bone morphogenetic protein and growth differentiation factor cytokine families and their protein antagonists. Biochem J 2010; 429: 1-12.
160. Qiu H, Yang B, Pei ZC, Zhang Z, Ding K. WSS25 inhibits growth of xenografted hepatocellular cancer cells in nude mice by disrupting angiogenesis via blocking BMP/SMAD/ID1 signaling J Biol Chem 2010; 285: 32638-32646.
161. Maegdefrau U, Arndt S, Kivorski G, Hellerbrand C, Bosserhoff AK. Downregulation of hemojuvelin prevents inhibitory effects of bone morphogenetic proteins on iron metabolism in hepatocellular carcinoma Lab Invest 2011.
162. Maegdefrau U, Amann T, Winklmeier A, et al. Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumour progression J Pathol 2009; 218: 520-529.
163. Kim SG, Jong HS, Kim TY, et al. Transforming growth factor-beta 1 induces apoptosis through Fas ligand-independent activation of the Fas death pathway in human gastric SNU-620 carcinoma cells Mol Biol Cell 2004; 15: 420-434.
164. Yu PB, Deng DY, Lai CS, et al. BMP type I receptor inhibition reduces heterotopic [corrected] ossification Nat Med 2008; 14: 1363-1369.
165. Vogt J, Traynor R, Sapkota GP. The specificities of small molecule inhibitors of the TGFss and BMP pathways Cell Signal 2011; 23: 1831-1842.
166. Theurl I, Schroll A, Sonnweber T, et al. Pharmacologic inhibition of hepcidin expression reverses anemia of chronic disease in rats Blood 2011.
167. Niessen K, Zhang G, Ridgway JB, Chen H, Yan M. ALK1 signaling regulates early postnatal lymphatic vessel development Blood 2010; 115: 1654-1661.
168. Hu-Lowe DD, Chen E, Zhang L, et al. Targeting activin receptorlike kinase 1 inhibits angiogenesis and tumorigenesis through a mechanism of action complementary to anti-VEGF therapies Cancer Res 2011; 71: 1362-1373.